Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze HBIO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate HBIO investment potential.

What is HBIO stock price today?

Get real-time HBIO stock price, historical data, and price charts on Financhill. Track HBIO performance with our advanced analysis tools.

Is HBIO a good investment?

Evaluate HBIO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy HBIO stock?

To buy HBIO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of HBIO?

View detailed market capitalization data and company valuation metrics for HBIO on our comprehensive analysis page.

What is the P/E ratio of HBIO?

Use our fundamental analysis tools to view HBIO P/E ratio and compare valuation metrics with industry peers.

What are HBIO earnings?

View HBIO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Harvard Bioscience, Inc. 10K Form

Sell

HBIO
Harvard Bioscience, Inc.

Last Price:

$5.21

Seasonality Move:

-0.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07	10Q	HBIO/Harvard Bioscience, Inc. Quarterly
2023-11-07	10Q	HBIO/Harvard Bioscience, Inc. Quarterly
2023-08-08	10Q	HBIO/Harvard Bioscience, Inc. Quarterly
2023-04-26	10Q	HBIO/Harvard Bioscience, Inc. Quarterly
2022-11-09	10Q	HBIO/Harvard Bioscience, Inc. Quarterly
2022-08-04	10Q	HBIO/Harvard Bioscience, Inc. Quarterly

Receive HBIO News And Ratings

See the #1 stock for the next 7 days that we like better than HBIO

HBIO Financial Statistics

Sales & Book Value

Annual Sales:	$86.6M
Cash Flow:	$-8K
Price / Cash Flow:	15.71
Annual Sales:	$3.07
Price / Book:	1.73

Profitability

EPS (TTM):	-2.57130
Net Income (TTM):	$-56.7M
Gross Margin:	$45.9M
Return on Equity:	-232.93%
Return on Assets:	-63.77%

Harvard Bioscience, Inc. Earnings Forecast

Key Harvard Bioscience, Inc. Financial Ratios

The Gross Profit Margin over the past 30 years for HBIO is 53.01%.
The Selling, General & Administrative Expenses for HBIO have been equal to 42.70% of Gross Profit Margin.
The Research & Development expenses have been 10.20% of Revenue.
The Net Earning history of HBIO is -65.51% of Total Revenues.
Per Share Earnings over the last 30 years have been positive in 15 years.

Harvard Bioscience, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Life Sciences Tools & Services
Sector:	Health Care
Current Symbol:	HBIO
CUSIP:	416906
Website:	harvardbioscience.com

Debt

Debt-to-Equity Ratio:	3.22
Current Ratio:	2.2
Quick Ratio:	1.13

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	6.65

HBIO Technical Analysis vs Fundamental Analysis